Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 358.19M P/E - EPS this Y -14.80% Ern Qtrly Grth -
Income -93.14M Forward P/E -3.31 EPS next Y 150.30% 50D Avg Chg -13.00%
Sales 8.12M PEG 0.38 EPS past 5Y - 200D Avg Chg -10.00%
Dividend N/A Price/Book 3.25 EPS next 5Y -6.40% 52W High Chg -48.00%
Recommedations 1.80 Quick Ratio 2.24 Shares Outstanding 77.18M 52W Low Chg 26.00%
Insider Own 24.25% ROA -36.66% Shares Float 25.09M Beta 1.29
Inst Own 53.91% ROE -91.51% Shares Shorted/Prior 1.95M/1.77M Price 6.02
Gross Margin 100.00% Profit Margin - Avg. Volume 139,854 Target Price 20.60
Oper. Margin -16,279.79% Earnings Date Nov 12 Volume 67,695 Change -0.82%
About MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. The company was incorporated in 2015 and is based in New York, New York.

MeiraGTx Holdings plc News
11/15/24 MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know
11/13/24 MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates
11/13/24 MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates
10/22/24 MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress
09:02 AM High Growth Tech Stocks to Watch in October 2024
10/16/24 MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study
10/16/24 MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study
10/16/24 MeiraGTx Holdings Reports Promising Parkinson’s Therapy Results
10/16/24 MeiraGTx (MGTX) Surges 14.9%: Is This an Indication of Further Gains?
10/15/24 Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints
10/15/24 MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease
10/09/24 MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference
10/07/24 MeiraGTx Holdings plc's (NASDAQ:MGTX) Profit Outlook
09/27/24 Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains?
09/09/24 Exploring Three High Growth Tech Stocks in the United States
08/30/24 Is MeiraGTx Holdings plc (MGTX) The Best Rated Penny Stock To Buy According to Analysts?
08/12/24 MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Lags Revenue Estimates
08/12/24 MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter 2024 Financial and Operational Results
08/12/24 MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
06/27/24 MeiraGTx Holdings (NASDAQ:MGTX) investors are sitting on a loss of 86% if they invested five years ago
MGTX Chatroom

User Image Helpmrwizard Posted - 9 hours ago

@ErnieWorthing84 Pretty amazing that $MGTX has 17,000 followers on LinkedIn- Not the retail crowd, either.

User Image ErnieWorthing84 Posted - 15 hours ago

$MGTX $SGMO Fireside chat with Peter Marks worth a watch https://www.fiercecellandgene.com/fiercecellandgenecom/cell-and-gene-2024

User Image ErnieWorthing84 Posted - 17 hours ago

$MGTX https://www.linkedin.com/posts/meiragtx_fierce-cell-and-gene-activity-7265052728853204995-5OF_?utm_source=share&utm_medium=member_ios

User Image ErnieWorthing84 Posted - 19 hours ago

$MGTX

User Image ErnieWorthing84 Posted - 1 day ago

$MGTX Looks like it's a good thing they got those RPDDs when they did...

User Image NyseDayTrader Posted - 1 day ago

$MGTX 5 years ago big pharma was looking into aquiring them for their retinal studies. Alot can advance in 5 years. The stock movement tells me alot, it had an aggressive rise. Someone always knows something.

User Image waterlock Posted - 2 days ago

$MGTX not yet, let short build up. Plz

User Image NyseDayTrader Posted - 2 days ago

$MGTX these are the times where a positive news release drops

User Image buylowandwait Posted - 2 days ago

$MGTX Give me 5, I want to load :-)

User Image valueforme Posted - 5 days ago

$MGTX No sellers here and we all understand why.

User Image Helpmrwizard Posted - 5 days ago

@valueforme Would not be shocked to see $MGTX next move up to be over $8 sp

User Image valueforme Posted - 5 days ago

$MGTX Golden cross on daily (5.13)

User Image deucestwits Posted - 6 days ago

$MGTX Love the prospects here..Holding bios ; clrb Noticing some fund adds..Got in Rgnx last week, Watching bdtx..See where market takes us.

User Image IN0V8 Posted - 1 week ago

$MGTX Opportunity RBC raises target price to $11 from $9

User Image Mikelonggggggggg Posted - 1 week ago

$MGTX Still a bargain!!!

User Image valueforme Posted - 1 week ago

$MGTX Rare Eye gene therapy candidates portfolio Worth a spin-off company itself

User Image NyseDayTrader Posted - 1 week ago

$MGTX should see some upgrades coming

User Image ErnieWorthing84 Posted - 1 week ago

$MGTX Good cash position, with line of sight to much more cash (up to a few hundred million just from vouchers); J&J data expected by EOY (remember JJ has already opened a long-term follow-up trial); aiming to get first riboswitch asset into clinic in 2025; Xerostomia trial is a pivotal, to conclude in July.

User Image NyseDayTrader Posted - 1 week ago

$MGTX through $7.30

User Image NyseDayTrader Posted - 1 week ago

$MGTX

User Image Stocks4thought Posted - 1 week ago

$MGTX S<moke

User Image jlemx Posted - 1 week ago

$MGTX and $SGMO the next generation of gene therapy

User Image MariaAAAAA Posted - 1 week ago

$MGTX https://investors.meiragtx.com/news-releases/news-release-details/meiragtx-announces-third-quarter-2024-financial-and-operational/

User Image ErnieWorthing84 Posted - 1 week ago

$MGTX Good stuff - bring on those vouchers...

User Image Helpmrwizard Posted - 1 week ago

@valueforme Yep, impulsive moves up on volume, followed by low volume down days, that sounds like a healthy up trend to me $mgtx

User Image valueforme Posted - 1 week ago

$MGTX It was traded today like someone was trying to find stop loss orders that retail might have

User Image ErnieWorthing84 Posted - 1 week ago

$MGTX This is potentially interesting, in the sense that Martha here works for Curation Connect, which Meira pays to promote them. So, it's a roundabout glimpse into what the company is thinking, and perhaps working on...

User Image MarthaRutherford Posted - 1 week ago

$MGTX GSK inked an $80mn deal, with up to another $570mn in milestones, with Vesalius Therapeutics to develop treatments targeting Parkinson’s disease using preclinical small molecule therapies, underscoring Big Pharma's increasing interest in neurodegenerative disease therapies. For peers like MeiraGTx, it signals potentially spurring more investment and partnerships in gene and targeted therapies. Find out more here:https://app.curationconnect.com/company/MeiraGTx-43926?utm_source=Stocktwits&utm_medium=Website

User Image Helpmrwizard Posted - 1 week ago

$MGTX Per nasdaq.com, in the month ending 10/31/2024 274,000 shorted shares were covered, leaving a balance of 1,660,883. I'd say we have a ways to go with this tail wind

User Image MGTX Posted - 1 week ago

$MGTX Again, MGTX is going to rise dramatically once its value is recognized. It's not about going up a buck or two. It's about going up 10-15 fold---minimum. Don't sell and keep buying...I am.

Analyst Ratings
RBC Capital Outperform Aug 13, 24
Chardan Capital Buy Jul 31, 24
RBC Capital Outperform Mar 15, 24
RBC Capital Outperform Aug 11, 23
Chardan Capital Buy Aug 11, 23
Piper Sandler Overweight May 12, 23
Chardan Capital Buy Mar 16, 23
RBC Capital Outperform Mar 15, 23
Chardan Capital Buy Aug 12, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
PERCEPTIVE ADVISORS LLC Director Director May 05 Buy 5.75 4,347,826 25,000,000 11,281,103 05/15/23
Zeldin Robert K CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Jun 03 Buy 7.9 5,000 39,500 5,000 06/06/22
Forbes Alexandria President and CEO President and CEO Nov 16 Sell 20.07 30,000 602,100 1,080,781 11/18/21
Giroux Richard CFO & COO CFO & COO Oct 19 Sell 20.76 22,000 456,720 819,218 10/21/21
Forbes Alexandria President and CEO President and CEO Oct 18 Sell 17.57 30,000 527,100 1,110,781 10/20/21